MSSG Voluntary Solidarity Mechanism

Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, (Multi trial) substantial modification, non-substantial modification, and Request for information (RFI)

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 4, Status: Authorised

Orphan designation: obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 19, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxinact H5, Avian influenza virus, subtype H5, haemagglutinin (recombinant), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Ecovaxxin MS, Mycoplasma synoviae, strain K588A, Live, Status: Opinion

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 2025

Summary of opinion: Credelio, 06/11/2025 Positive